Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer

Amy K. Wehn, Ping Qiu, Jared Lunceford, Alexander Yarunin, Răzvan Cristescu, Li Liu, Kyria Roessler, Sven Bilke, John Day, Kirsten M. Timms, Wilko Weichert, Matthew J. Marton